Programming the magnitude and persistence of antibody responses with innate immunity
| Autor: | Tang Hua, Joshy Jacob, Niren Murthy, Adolfo García-Sastre, Robert J. Hogan, Sudhir Pai Kasturi, Ioanna Skountzou, Bali Pulendran, Rajesh Ravindran, Dimitrios G. Koutsonanos, Randy A. Albrecht, Munir Alam, Richard W. Compans, Marcin Kwissa, Francois Villinger, Shelley Stewart, John Steel, Helder I. Nakaya |
|---|---|
| Rok vydání: | 2011 |
| Předmět: |
T-Lymphocytes
Plasma Cells Hemagglutinin Glycoproteins Influenza Virus 02 engineering and technology Biology Antibodies Viral Ligands Lymphocyte Activation medicine.disease_cause Mice 03 medical and health sciences Influenza A Virus H1N1 Subtype Polylactic Acid-Polyglycolic Acid Copolymer Antigen Immunity Influenza A virus medicine Animals Lactic Acid 030304 developmental biology Mice Inbred BALB C 0303 health sciences Multidisciplinary Innate immune system Influenza A Virus H5N1 Subtype Toll-Like Receptors Germinal center Dendritic Cells TLR7 021001 nanoscience & nanotechnology Antibodies Neutralizing Macaca mulatta Virology Immunity Innate 3. Good health Mice Inbred C57BL Influenza Vaccines Antibody Formation Immunology biology.protein TLR4 Nanoparticles Lymph Nodes Antibody 0210 nano-technology Immunologic Memory Polyglycolic Acid |
| Zdroj: | Nature. 470:543-547 |
| ISSN: | 1476-4687 0028-0836 |
| Popis: | A feature of many successful vaccines is the induction of memory B cells and long-lived plasma cells that can secrete neutralizing antibodies for a lifetime. The mechanisms that stimulate such persistent responses remain poorly understood. Bali Pulendran and colleagues show that nanoparticles containing two Toll-like receptor ligands, proteins with important roles in innate immunity, can boost the magnitude and persistence of vaccine-elicited antibody responses in primates, improving vaccine-mediated protection against influenza virus. Here it is shown that nanoparticles containing two Toll-like receptor ligands can boost the magnitude and persistence of vaccine-elicited antibody responses in primates, improving vaccine-mediated protection against influenza virus. Many successful vaccines induce persistent antibody responses that can last a lifetime. The mechanisms by which they do so remain unclear, but emerging evidence indicates that they activate dendritic cells via Toll-like receptors (TLRs)1,2. For example, the yellow fever vaccine YF-17D, one of the most successful empiric vaccines ever developed3, activates dendritic cells via multiple TLRs to stimulate proinflammatory cytokines4,5. Triggering specific combinations of TLRs in dendritic cells can induce synergistic production of cytokines6, which results in enhanced T-cell responses, but its impact on antibody responses remain unknown. Learning the critical parameters of innate immunity that program such antibody responses remains a major challenge in vaccinology. Here we demonstrate that immunization of mice with synthetic nanoparticles containing antigens plus ligands that signal through TLR4 and TLR7 induces synergistic increases in antigen-specific, neutralizing antibodies compared to immunization with nanoparticles containing antigens plus a single TLR ligand. Consistent with this there was enhanced persistence of germinal centres and of plasma-cell responses, which persisted in the lymph nodes for >1.5 years. Surprisingly, there was no enhancement of the early short-lived plasma-cell response relative to that observed with single TLR ligands. Molecular profiling of activated B cells, isolated 7 days after immunization, indicated that there was early programming towards B-cell memory. Antibody responses were dependent on direct triggering of both TLRs on B cells and dendritic cells, as well as on T-cell help. Immunization protected completely against lethal avian and swine influenza virus strains in mice, and induced robust immunity against pandemic H1N1 influenza in rhesus macaques. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|